InProTher pitch at Novo BII demo-day by Peter J. Holst
InProTher treats cancer by target tumor virus within the human genome. In this video you can learn more about the company, where InProTher is presented by Associate Professor Peter Johannes Holst.
Inprother got investment by Novo Nordisk Foundation
InProTher is one of the three companies to join the BII Creation House program run by Novo Nordisk Foundation. After a successful Business Acceleration Academy, InProTher was recommended for the program by an external committee and approved by the BII Board of Directors. In the…